BCL11B up-regulates NKG2D ligands of the major histocompatibility complex class I-related molecules A and B (MICA and MICB), promotes the anti-tumor response of T- and NK-cells and prevents immune evasion of colon cancer cells (21). This evidence concerns the gene BCL11B and malignant colon neoplasm.